Biblio Discovery — Demo Discovery Service

18 hasil untuk "Francesca Morelli"

Menampilkan 1–18 · 1,53 detik · RSS

  1. Artikel Jurnal

    Il ruolo del Design per la valorizzazione dei Musei d’Impresa nell’era digitale

    Francesca Morelli

    ZoneModa Journal, Vol. 14 No. 2 · 2025 · Italia · DOAJ

    In line with the latest trends, the museum system is increasingly integrating digital tools to enhance the visitor experience, making it more engaging, immersive, and interactive. The implementation of these digital solutions not only revitalizes the museum and sustains public interest, but also…

  2. Artikel Jurnal Teks lengkap

    Disaster-Affected Spaces as Multisensory Living Labs. Comfort and Regeneration through the Reuse of Abandoned Spaces.

    Laura Giraldi; Francesca Morelli

    Pad, Vol. 19 No. 30 · 2026 · Inggris · DOAJ

    Disaster-affected environments are often framed as remnants to be secured, remem- bered, or replaced, overlooking their potential as multisensory spaces where perception, memory, and embodied experience intersect. This paper reinterprets post-earthquake abandoned architectures as multisensory…

  3. Artikel Jurnal

    From Hypogeum to Empyrean. Architecture of the Palimpsest and Phenomenology of Light on the Via Appia

    Concetta Tavoletta; Francesca Morelli

    Proceedings of the International Conference of Contemporary Affairs in Architecture and…, Vol. 9 No. 1 · 2026 · Inggris · DOAJ

    The project interprets the archaeological heritage of the Via Appia Antica, in the suburban area of Rome, as a dynamic cultural landscape and an active palimpsest. By intervening in the area adjacent to the hypogea of the Hunters and of Vibia, the objective is to redefine the hypogeal identity of…

  4. Artikel Jurnal Teks lengkap

    Design, Technology, and Cultural Expressions in Contemporary and Future Forms of Nomadic Living

    Laura Giraldi; Francesca Morelli; Marta Maini

    Pad, Vol. 18 No. 28 · 2025 · Inggris · DOAJ

    The concept of dwelling is undergoing a profound transformation as societal shifts, technological advancements, and environmental imperatives redefine our understanding of permanence and mobility. Historically rooted in the nomadic practices of Bedouins, Tuareg, and other itinerant cultures, moving…

  5. Artikel Jurnal

    Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia

    Francesca Morelli; Silvia Linari; Chiara Maria Rapolla dkk.

    Annals of Hematology, Vol. 105 No. 4 · 2026 · Inggris · DOAJ Scopus

    Abstract Venetoclax-obinutuzumab therapy successfully induced remission of acquired von Willebrand syndrome (AVWS) in a 72-year-old patient with chronic lymphocytic leukemia (CLL). Initially diagnosed with CLL, the patient later experienced severe bleeding due to AVWS, as evidenced by reduced…

  6. Artikel Jurnal

    Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability

    Roberta S. Azevedo; Francesca Morelli; Kiyomi Mashima dkk.

    Haematologica, Vol. 999 No. 1 · 2024 · Inggris · DOAJ Scopus

    Chronic lymphocytic leukemia (CLL) patients have an increased risk of secondary cancers, along with predisposition to CLL in their relatives. We have previously identified germline ATM variants as associated with CLL risk; here, we present their impact on predisposition to secondary neoplasms in…

  7. Artikel Jurnal

    Case Report: The role of BRAF mutation in adjuvant and neoadjuvant treatment of melanoma patients: what is the optimal approach?

    Francesca Romana Di Pietro; Rosa Falcone; Sofia Verkhovskaia dkk.

    Frontiers in Oncology, Vol. 16 · 2026 · Inggris · DOAJ Scopus

    BackgroundWhile the benefit of adjuvant therapy is well established in patients with stage IIIB–IIID melanoma, its role in stage IIIA disease remains a matter of discussion. This subgroup is generally considered to be at lower risk of recurrence, whereas currently available treatments are…

  8. Artikel Jurnal

    Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients

    Francesca Romana Di Pietro; Sofia Verkhovskaia; Rosa Falcone dkk.

    Frontiers in Oncology, Vol. 14 · 2024 · Inggris · DOAJ Scopus

    BackgroundStage III surgically resected melanoma is a disease at high risk of recurrence. Immune checkpoint inhibitors (ICIs) and the target therapy with BRAF and MEK inhibitors significantly changed the outcome of patients with metastatic melanoma and several studies have also shown their benefit…

  9. Artikel Jurnal Teks lengkap

    Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center

    Rosa Falcone; Sofia Verkhovskaia; Francesca Romana Di Pietro dkk.

    Current Oncology, Vol. 31 No. 1 · 2024 · Inggris · DOAJ Scopus

    (1) Background: Mucosal melanoma (MM) is a rare tumor, accounting for about 1% of all diagnosed melanomas. The etiology and pathogenesis of this tumor are unknown. It is characterized by an aggressive phenotype with poor prognosis and a low response rate to approved treatments. (2) Methods: We…

  10. Artikel Jurnal

    Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience

    Francesca Romana Di Pietro; Daniele Marinelli; Sofia Verkhovskaia dkk.

    BMC Cancer, Vol. 24 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Immunotherapy with anti-PD-1 antibodies significantly improved the prognosis in advanced melanoma patients, but most of them develop primary or secondary resistance to the treatment. In this study, we evaluated efficacy and safety of a chemotherapy regimen with weekly carboplatin plus…

  11. Artikel Jurnal

    Research infrastructures as engines of integration for micro- and nanomaterial research: a European perspective inspired by FHERITALE

    Elisa Murgioni; Ondřej Adamovský; Nastasia Belc dkk.

    Food Safety and Risk, Vol. 13 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Micro- and nanomaterials have become pervasive across ecosystems, food systems, and human environments, raising urgent questions about exposure, toxicity, and long-term impacts. Yet despite rapid scientific advances, the research landscape remains fragmented, with inconsistent terminology…

  12. Artikel Jurnal

    Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

    Anna Maria Frustaci; Giovanni Del Poeta; Andrea Visentin dkk.

    Therapeutic Advances in Hematology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Background: The question of which parameters may be informative on venetoclax outcome in chronic lymphocytic leukemia (CLL) is still unclear. Furthermore, the choice to treat with venetoclax can be challenging in patients with baseline characteristics or comorbidities that may potentially favor…

  13. Artikel Jurnal

    Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact [version 1; peer review: 1 approved, 2 approved with reservations]

    Nicolas Collin; Donata Medaglini; Arjen Sloots dkk.

    F1000Research, Vol. 12 · 2023 · Inggris · DOAJ Scopus

    Background Research infrastructures are facilities or resources that have proven fundamental for supporting scientific research and innovation. However, they are also known to be very expensive in their establishment, operation and maintenance. As by far the biggest share of these costs is always…

  14. Artikel Jurnal

    Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study

    Alberto Fresa; Idanna Innocenti; Annamaria Tomasso dkk.

    Blood Advances, Vol. 9 No. 21 · 2025 · Inggris · DOAJ Scopus

    Abstract: Familial chronic lymphocytic leukemia (CLL) constitutes 5% to 7% of CLL and has previously shown a more aggressive pattern of evolution than sporadic CLL, even if no difference in overall survival (OS) has been observed. This multicenter case-control study aimed to compare clinical…

  15. Artikel Jurnal

    Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational studyResearch in context

    Melissa Bersanelli; Elena Verzoni; Alessio Cortellini dkk.

    EClinicalMedicine, Vol. 61 · 2023 · Inggris · DOAJ Scopus

    Summary: Background: The prospective multicentre observational INVIDIa-2 study investigated the clinical effectiveness of influenza vaccination in patients with advanced cancer receiving immune checkpoint inhibitors (ICI). In this secondary analysis of the original trial, we aimed to assess the…